FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/22/2023
Back to search
Official data from USPTO
EXOREPLACE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXOREPLACE
ST13
US500000079330499Class
5, 42, 44
Filing
79330499
Registration
6998492
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/22/2023
Trademark type
Word
Nice classes
5, 42, 44
Filing date
07/23/2021
Registration date
03/14/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/14/2023
Last transaction
03/14/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
WOLD, BARBARA
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Evox Therapeutics Limited
Representatives
Nancy Sabarra Fross Zellnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; pharmaceutical preparationsa drug delivery system comprising genetically engineered or purified exosomes in the form of a liquid solution or lyophilised preparation for therapeutic use for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; pharmaceutical preparationsexosomes to deliver protein or nucleic acids or viral vectors for genetic therapy; medicine for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; Medical preparations for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations for medical purposes for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; biological preparations comprising exosome for the treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; biological preparations comprising a therapeutic target protein-loadednucleic acid-loaded or virus-loaded exosome for the treatment of genetic diseasesrespiratory diseasescancer; biological reagents for medical use; biological preparations for medical purposesfor the prevention and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disordersurea cycle disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; mixed biological preparations for the prevention and treatment of infectious diseases; pharmaceuticalsmedicinesbiologicsbiotherapeuticsbiosimilars and therapeuticsEV-based nucleic acid therapeutic agents for the prevention and treatment of infections or disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint/ligament strain/tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders
Class 42
Scientificmedical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientific research and analysis services; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from cultured cells or blood; scientific investigations for medical purposes; scientific laboratory services; medical laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of genetic diseasescancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; informationadvisory and consultancy services relating to the aforesaidscientificmedical and pharmaceutical research and development servicespharmaceutical drug development servicesresearch and development of pharmaceutical preparationsscientific research and analysis servicesbiological researchclinical research in the field of transformational therapeuticsproviding medical and scientific research information in the field of filtration of exosomes from cultured cells or bloodscientific investigations for medical purposesscientific laboratory servicesmedical laboratory serviceslaboratory research services relating to pharmaceuticalsresearch and development in the field of biotherapeutics for the treatment of genetic diseasescancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disordersbiotechnologypharmaceutical research and development and genetic sciencelaboratory diagnosticsmedical analysis services relating to the diagnosis and treatment of persons provided by medical laboratories
Class 44
Medical services; medical and pharmaceutical consultancy; medical diagnosticsmedical testingmonitoringreporting services for diagnostic or treatment purposes; medical analysis services for the diagnosis and treatment of persons and for the diagnosis and treatment of genetic diseases; medical examination services; medical treatment services in the field of biotherapeutics for the treatment of infectious diseasescancerneurological disordersneurodegenerative disordersinflammatory disordersrare diseasesgenetic and metabolic disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseases; medical screening; medical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerviral and bacterial based infections and diseases; medical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tearsligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders; informationadvisory and consultancy services relating to the aforesaidmedical servicesmedical and pharmaceutical consultancymedical diagnosticsmedical testingmonitoringreporting servicesmedical analysis services for the diagnosis and treatment of persons and for the diagnosis and treatment of genetic diseasesmedical examination servicesmedical treatment services in the field of biotherapeutics for the treatment of infectious diseasescancerneurological disordersneurodegenerative disordersinflammatory disordersrare diseasesgenetic and metabolic disordersliver disorders and diseasesbrain diseaseseye disorders and diseases and lung disorders and diseasesmedical screeningmedical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerviral and bacterial based infections and diseasesmedical monitoringtestinginspection and analysis services relating to the diagnosis and treatment of cancerdiabetesobesitymetabolic syndromedementiaother aging associated pathologies being mitochondrial diseasejoint strain and tears and ligament strain and tearsmuscle atrophymuscular dystrophyneuromuscular diseasesneurological disordersneurodegenerative disordersinflammatory disordersinfectious diseasesgenetic diseasesrare diseasesin-born errors of metabolism (IEMs)lysosomal storage disorders and urea cycle disorders
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/28/2023
FIMP
FINAL DISPOSITION PROCESSED
06/28/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/14/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/14/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/27/2022
PUBO
PUBLISHED FOR OPPOSITION
12/27/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/21/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/21/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/21/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/21/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/21/2022
RFNT
REFUSAL PROCESSED BY IB
05/10/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/21/2022
RFRR
REFUSAL PROCESSED BY MPU
04/21/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/20/2022
CNRT
NON-FINAL ACTION WRITTEN
04/19/2022
DOCK
ASSIGNED TO EXAMINER
04/19/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/06/2022
Continuous trademark protection
Get notified about every new filing that threatens EXOREPLACE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.